The global procurement landscape of leishmaniasis medicines.
Ensuring access to essential medicines for leishmaniasis control is challenging, as leishmaniasis is a very small and unattractive market for pharmaceutical industry. Furthermore, control programmes are severely underfunded. We conducted an analysis of global procurement of leishmaniasis medicines f...
Published in: | PLOS Neglected Tropical Diseases |
---|---|
Main Authors: | , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doi.org/10.1371/journal.pntd.0009181 https://doaj.org/article/cef4c0edaa8f4700955ea4bc6a334951 |
id |
ftdoajarticles:oai:doaj.org/article:cef4c0edaa8f4700955ea4bc6a334951 |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:cef4c0edaa8f4700955ea4bc6a334951 2023-05-15T15:13:22+02:00 The global procurement landscape of leishmaniasis medicines. Hye Lynn Choi Saurabh Jain José A Ruiz Postigo Bettina Borisch Daniel Argaw Dagne 2021-02-01T00:00:00Z https://doi.org/10.1371/journal.pntd.0009181 https://doaj.org/article/cef4c0edaa8f4700955ea4bc6a334951 EN eng Public Library of Science (PLoS) https://doi.org/10.1371/journal.pntd.0009181 https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 doi:10.1371/journal.pntd.0009181 https://doaj.org/article/cef4c0edaa8f4700955ea4bc6a334951 PLoS Neglected Tropical Diseases, Vol 15, Iss 2, p e0009181 (2021) Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2021 ftdoajarticles https://doi.org/10.1371/journal.pntd.0009181 2022-12-31T13:53:26Z Ensuring access to essential medicines for leishmaniasis control is challenging, as leishmaniasis is a very small and unattractive market for pharmaceutical industry. Furthermore, control programmes are severely underfunded. We conducted an analysis of global procurement of leishmaniasis medicines for the past 5 years in order to shed light on the current leishmaniasis market landscape and supply and demand dynamics. We estimated global demand of each leishmaniasis medicines, the amount of each medicine required to treat all reported cases, based on the number of cases reported to WHO and the first-line treatment regimen used in each country. Procurement data were obtained from procurement agencies, international organizations, WHO, national leishmaniasis programmes and manufacturers. Expert interviews were conducted to have a better understanding of how medicines were procured and used. The comparison of estimated need and procurement data indicated discrepancies in supply and demand at global level as well as in the most endemic countries. The extent of the gap in supply was up to 80% of the needs for one of the leishmaniasis medicines. Mismatch between supply and demand was much wider for cutaneous leishmaniasis than visceral leishmaniasis. This study presents a current picture of procurement patterns and imbalance in global supply and demand. Addressing improved access and supply barriers requires concerted and coordinated efforts at the global and national levels. Priority actions include setting up a procurement coordination mechanism among major procurers, partners and national programmes where forecasting and supply planning is jointly developed and communicated with manufacturers. In addition, continuous engagement of manufacturers and advocacy is critical to diversify the supplier base and ensure quality-assured and affordable generic medicines for leishmaniasis. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic PLOS Neglected Tropical Diseases 15 2 e0009181 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Hye Lynn Choi Saurabh Jain José A Ruiz Postigo Bettina Borisch Daniel Argaw Dagne The global procurement landscape of leishmaniasis medicines. |
topic_facet |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
description |
Ensuring access to essential medicines for leishmaniasis control is challenging, as leishmaniasis is a very small and unattractive market for pharmaceutical industry. Furthermore, control programmes are severely underfunded. We conducted an analysis of global procurement of leishmaniasis medicines for the past 5 years in order to shed light on the current leishmaniasis market landscape and supply and demand dynamics. We estimated global demand of each leishmaniasis medicines, the amount of each medicine required to treat all reported cases, based on the number of cases reported to WHO and the first-line treatment regimen used in each country. Procurement data were obtained from procurement agencies, international organizations, WHO, national leishmaniasis programmes and manufacturers. Expert interviews were conducted to have a better understanding of how medicines were procured and used. The comparison of estimated need and procurement data indicated discrepancies in supply and demand at global level as well as in the most endemic countries. The extent of the gap in supply was up to 80% of the needs for one of the leishmaniasis medicines. Mismatch between supply and demand was much wider for cutaneous leishmaniasis than visceral leishmaniasis. This study presents a current picture of procurement patterns and imbalance in global supply and demand. Addressing improved access and supply barriers requires concerted and coordinated efforts at the global and national levels. Priority actions include setting up a procurement coordination mechanism among major procurers, partners and national programmes where forecasting and supply planning is jointly developed and communicated with manufacturers. In addition, continuous engagement of manufacturers and advocacy is critical to diversify the supplier base and ensure quality-assured and affordable generic medicines for leishmaniasis. |
format |
Article in Journal/Newspaper |
author |
Hye Lynn Choi Saurabh Jain José A Ruiz Postigo Bettina Borisch Daniel Argaw Dagne |
author_facet |
Hye Lynn Choi Saurabh Jain José A Ruiz Postigo Bettina Borisch Daniel Argaw Dagne |
author_sort |
Hye Lynn Choi |
title |
The global procurement landscape of leishmaniasis medicines. |
title_short |
The global procurement landscape of leishmaniasis medicines. |
title_full |
The global procurement landscape of leishmaniasis medicines. |
title_fullStr |
The global procurement landscape of leishmaniasis medicines. |
title_full_unstemmed |
The global procurement landscape of leishmaniasis medicines. |
title_sort |
global procurement landscape of leishmaniasis medicines. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doi.org/10.1371/journal.pntd.0009181 https://doaj.org/article/cef4c0edaa8f4700955ea4bc6a334951 |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
PLoS Neglected Tropical Diseases, Vol 15, Iss 2, p e0009181 (2021) |
op_relation |
https://doi.org/10.1371/journal.pntd.0009181 https://doaj.org/toc/1935-2727 https://doaj.org/toc/1935-2735 1935-2727 1935-2735 doi:10.1371/journal.pntd.0009181 https://doaj.org/article/cef4c0edaa8f4700955ea4bc6a334951 |
op_doi |
https://doi.org/10.1371/journal.pntd.0009181 |
container_title |
PLOS Neglected Tropical Diseases |
container_volume |
15 |
container_issue |
2 |
container_start_page |
e0009181 |
_version_ |
1766343931595849728 |